Literature DB >> 159937

B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.

I F McKenzie, G M Morgan, M S Sandrin, M M Michaelides, R W Melvold, H I Kohn.   

Abstract

The B6.C-H-2bm12 mutant is described and evidence is presented for the mutational site occurring in the IA subregion. The mutant is of the gain and loss type as bm12 in equilibrium or formed from C57BL/6 grafts are rejected in 14-16 d. Mapping studies by the gene-complementation method using H-2 recombinant strains place the mutation in the K or IA regions of the H-2 complex and furthermore, the use of this test and the use of other H-2 mutants indicate that H-2Kb is not the site of the mutation, making the IA region the most likely site. Serological analysis with a battery of H-2b, Iab, and other Ia sera, both by cytotoxicity, rosetting, and also by absorption analysis, indicated no alteration in H-2 specificities, particularly in H-2.K33. By contrast, all of the Iab specificities coded for by the IA subregion (Ia.3, 8, 9, 15, and possibly 20) are extensively altered and are either absent or greatly reduced in amount indicating an extensive alteration in the Ia-bearing molecule. The bm12 mutant strongly stimulates the parental C57BL/6 strain in an mixed lymphocyte reaction (MLR), and the reciprocal also occurs, the degree of stimulation being similar to that obtained with K + IA differences originating in another H-2 haplotype and points to the mutation effecting the Lad-1 locus. The presence of an extensive histocompatibility change, a marked alteration in the serologically detected Ia specificities, and a strong MLR, all produced by the one mutation, provides strong evidence for the identity of the Ia-1, Lad-1, and H-2(IA) loci in the IA subregion. The bm12 mutant should be of value in determining the relationship of Ia specificities, Ir genes, and other phenomena effected by the I region.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159937      PMCID: PMC2185725          DOI: 10.1084/jem.150.6.1323

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Structural polymorphism of I-E subregion antigens determined by a gene in the H-2K to I-B genetic interval.

Authors:  J Silver; W A Russell
Journal:  Nature       Date:  1979-05-31       Impact factor: 49.962

2.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

3.  A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera.

Authors:  C R Parish; I F McKenzie
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

4.  Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex.

Authors:  S E Cullen; C S David; J L Cone; D H Sachs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

Review 5.  Genetic and functional analysis of the Ia antigens: their possible role in regulating the immune response.

Authors:  H O McDevitt; T L Delovitch; J L Press; D B Murphy
Journal:  Transplant Rev       Date:  1976

6.  Structural differences between parent and mutant H-2K glycoproteins from two H-2K gene mutants: b6.c-h-2ba (Hzl) and B6-H-2bd (M505).

Authors:  J L Brown; S G Nathenson
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

7.  Structural differences between the mouse H-2D products of the mutant B10.D2.M504 (H-2da) and the parental nonmutant strain B10.D2 (H-2d).

Authors:  J L Brown; R Nairen; S G Natherson
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

8.  Two-gene control of the expression of a murine Ia antigen.

Authors:  P P Jones; D B Murphy; H O McDevitt
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse.

Authors:  F H Bach; M B Widmer; M L Bach; J Klein
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

  9 in total
  64 in total

Review 1.  T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection.

Authors:  H Auchincloss; T Mayer; R Ghobrial; H J Winn
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Distinct regulation of humoral and cellular immunities to hepatitis B surface antigen.

Authors:  H Y Lei; S C Lee; C K Yu
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

Review 3.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

4.  Allogeneic substitution for nominal antigen-specific T-cell clone reactivity in schistosomiasis.

Authors:  G P Linette; P J Lammie; S M Phillips
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

5.  Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.

Authors:  L Rozendaal; S T Pals; E Gleichmann; C J Melief
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

6.  Synthetic macrophages: antigen presentation by liposomes bearing class II major histocompatibility complex (MHC) and membrane interleukin-1 (IL-1).

Authors:  O Bakouche; L B Lachman
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

7.  A biochemical analysis of Ak molecules from mutant antigen presenting cell lines.

Authors:  S Chatterjee-Das; G G Schlauder; D H Sachs; L H Glimcher; W E Paul; D J McKean
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Skin graft rejection and delayed-type hypersensitivity responses to H-Y in an I-Ab mutant.

Authors:  I F McKenzie; M M Henning; M Michaelides
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.

Authors:  Joseph H Chewning; Weiwei Zhang; David A Randolph; C Scott Swindle; Trenton R Schoeb; Casey T Weaver
Journal:  Biol Blood Marrow Transplant       Date:  2013-03-21       Impact factor: 5.742

10.  Inhibition of antigen-induced proliferation of T cells from radiation-induced bone marrow chimeras by a monoclonal antibody directed against an Ia determinant on the antigen-presenting cell.

Authors:  D L Longo; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.